Visión generalGráficoNoticiasTraderScreen

ING Knock-Out UCB/  DE000NG8UJ36  /

Frankfurt Zertifikate
15/11/2024  16:43:41 Diferencia-1.280 Bid17:29:17 Ask17:29:17 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
8.330EUR -13.32% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 UCB SA 83.3768 EUR 31/12/2078 Call
GlobeNewswire 26/08 Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice...
GlobeNewswire 26/08 MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign wi...
GlobeNewswire 15/08 United Community Banks, Inc. Announces Increased Quarterly Cash Dividend and Larger Share Repurchase...
GlobeNewswire 13/08 Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Resul...
GlobeNewswire 26/07 United Community Banks, Inc. Announces Transfer of Listing of Common Stock and Depositary Shares to ...
GlobeNewswire 08/07 Conflicting Views Between Epileptologists and General Neurologists Hinder Adoption of New Refractory...
GlobeNewswire 28/06 United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference ...
GlobeNewswire 04/06 Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘...
GlobeNewswire 04/06 ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
GlobeNewswire 03/06 7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 01/05 Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
GlobeNewswire 30/04 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire 30/04 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire 15/04 London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire 01/04 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 25/03 Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire 05/03 Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire 05/03 Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire 28/02 Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire 16/02 United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire 08/02 Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire 22/01 Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
GlobeNewswire 15/01 ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron...
GlobeNewswire 07/01 Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...